Research.Patient.info
Metastatic Pancreatic Ductal Adenocarcinoma research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
This study is testing a new drug, quemliclustat, alongside standard chemotherapy for pancreatic cancer that has spread. Researchers want to see if adding quemliclustat helps people live longer compared to chemotherapy alone. It's a phase 3 trial, meaning it's in the final stages of testing.
United States · Australia · Austria - ongoing, recruitingPhase II and Phase III (Integrated)
A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With Or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma
This study is testing a new drug, SBP-101, alongside standard treatments (Nab-paclitaxel and Gemcitabine) for advanced pancreatic cancer that hasn't been treated before. Researchers want to see if adding SBP-101 helps people live longer.
Italy · Belgium · Germany